GeoPharma Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Mar 08 | Mar 07 | Mar 06 | |
|---|---|---|---|
| Revenue | 55.0 | 59.8 | 49.7 |
| Cost of Goods Sold | 44.0 | 42.9 | 37.3 |
| Gross Profit | 10.9 | 16.9 | 12.5 |
| Gross Profit Margin | 19.9% | 28.2% | 25.0% |
| SG&A Expense | 18.0 | 12.8 | 9.1 |
| Depreciation & Amortization | 2.8 | 2.8 | 1.4 |
| Operating Income | (9.9) | 1.3 | 2.0 |
| Operating Margin | -- | 2.1% | 4.0% |
| Nonoperating Income | 0.0 | 0.3 | 0.9 |
| Nonoperating Expenses | 0.6 | -- | 0.6 |
| Income Before Taxes | (10.4) | 1.5 | 2.3 |
| Income Taxes | (2.5) | 0.3 | 1.1 |
| Net Income After Taxes | (7.9) | 1.2 | 1.2 |
| Continuing Operations | (7.0) | 2.5 | 1.8 |
| Discontinued Operations | 0.0 | -- | -- |
| Total Operations | (7.0) | 2.5 | 1.8 |
| Total Net Income | (7.0) | 2.5 | 1.8 |
| Net Profit Margin | -- | 4.2% | 3.6% |
| Diluted EPS from Total Net Income ($) | (0.59) | 0.19 | 0.14 |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
